Hyderabad, India
Dr. Reddy's Laboratories, founded in 1984, is a global pharmaceutical powerhouse headquartered in Hyderabad, India. Embodying the motto: "We accelerate access to affordable and innovative medicines because Good Health Can’t Wait," the company emphasizes delivering accessible healthcare solutions worldwide.
Dr. Reddy's offers a diverse portfolio encompassing APIs, generics, branded generics, biosimilars, and OTC products, with primary markets spanning the USA, India, Russia & CIS countries, China, Brazil, and Europe. The company's legacy in deep science has resulted in numerous industry advancements, and it is strategically investing in future innovation areas like novel molecules, digital therapeutics, and consumer healthcare.
A commitment to sustainability, evident since releasing its first Sustainability Report in 2004, underscores Dr. Reddy's dedication to high ESG standards, including environmental stewardship and diversity. Investors will find a firm deeply embedded in science, poised for future growth, and resolutely driving towards impactful global health improvements.
